A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness
PHASE2
This study is a 4-week, multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
Southern California Institute For Respiratory Diseases, Inc.
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Solriamfetol in the Treatment of Excessive Daytime Sleepiness (EDS) in Patients with Obstructive Sleep Apnea (OSA)
PHASE3
The purpose of this study is to evaluate the efficacy and safety of 12-week...